Angiosuppressive therapy for cancer
- 28 February 1994
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 15 (2) , 33-36
- https://doi.org/10.1016/0165-6147(94)90103-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesisEndocrinology, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Antitumor effects of GBS toxin: a polysaccharide exotoxin from group B?-hemolytic streptococcusZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes.The Journal of cell biology, 1992
- Angiogenesis.Journal of Biological Chemistry, 1992
- Linking cellular injury to gene expression and human proliferative disorders: Examples with the pdgf genesMolecular Carcinogenesis, 1992
- Assays for angiogenesis: A reviewPharmacology & Therapeutics, 1991
- Growth Inhibition of Murine Melanoma and Human Colon Carcinoma by Recombinant Human Platelet Factor 4JNCI Journal of the National Cancer Institute, 1990
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986